ES2104507A1 - Use of gelatin hydrolysate to prepare a pharmaceutical composition intended for the prevention and treatment of hip dysplasia in dogs. - Google Patents
Use of gelatin hydrolysate to prepare a pharmaceutical composition intended for the prevention and treatment of hip dysplasia in dogs.Info
- Publication number
- ES2104507A1 ES2104507A1 ES09500449A ES9500449A ES2104507A1 ES 2104507 A1 ES2104507 A1 ES 2104507A1 ES 09500449 A ES09500449 A ES 09500449A ES 9500449 A ES9500449 A ES 9500449A ES 2104507 A1 ES2104507 A1 ES 2104507A1
- Authority
- ES
- Spain
- Prior art keywords
- dogs
- prepare
- pharmaceutical composition
- composition intended
- prevention
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Use of gelatin hydrolysate to prepare a pharmaceutical composition intended for the prevention and treatment of hip dysplasia in dogs. The present invention relates to the use of a highly purified gelatin hydrolysate to prepare a pharmaceutical composition intended to be administered to young dogs, principally dogs of those species with greater predisposition to develop hip dysplasia, such as occurs with the German shepherd, Rottweiler and mastiff, among others, with the aim of preventing it, as well as to adult dogs in the first stages of the disease, and also to those which are in the inflammatory phase of said disease.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES9500449A ES2104507B1 (en) | 1995-03-07 | 1995-03-07 | USE OF GELATIN HYDROLYZATE TO PREPARE A PHARMACEUTICAL COMPOSITION INTENDED FOR THE PREVENTION AND TREATMENT OF HIP DYSPLASIA IN DOGS. |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES9500449A ES2104507B1 (en) | 1995-03-07 | 1995-03-07 | USE OF GELATIN HYDROLYZATE TO PREPARE A PHARMACEUTICAL COMPOSITION INTENDED FOR THE PREVENTION AND TREATMENT OF HIP DYSPLASIA IN DOGS. |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2104507A1 true ES2104507A1 (en) | 1997-10-01 |
ES2104507B1 ES2104507B1 (en) | 1998-07-01 |
Family
ID=8289693
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES9500449A Expired - Fee Related ES2104507B1 (en) | 1995-03-07 | 1995-03-07 | USE OF GELATIN HYDROLYZATE TO PREPARE A PHARMACEUTICAL COMPOSITION INTENDED FOR THE PREVENTION AND TREATMENT OF HIP DYSPLASIA IN DOGS. |
Country Status (1)
Country | Link |
---|---|
ES (1) | ES2104507B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999048516A1 (en) * | 1998-03-25 | 1999-09-30 | Masterfarm, S.L. | Utilization of gelatine hydrolizats |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4772476A (en) * | 1986-03-12 | 1988-09-20 | Ralston Purina Company | Method for reducing the severity of hip joint laxity in dogs |
US4866082A (en) * | 1988-04-06 | 1989-09-12 | American Home Products Corporation | Inhibition of bone loss by (-)-N-[[(5-chloro-2-benzothiazolyl)thio]phenylacetyl]-L-cysteine |
-
1995
- 1995-03-07 ES ES9500449A patent/ES2104507B1/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4772476A (en) * | 1986-03-12 | 1988-09-20 | Ralston Purina Company | Method for reducing the severity of hip joint laxity in dogs |
US4866082A (en) * | 1988-04-06 | 1989-09-12 | American Home Products Corporation | Inhibition of bone loss by (-)-N-[[(5-chloro-2-benzothiazolyl)thio]phenylacetyl]-L-cysteine |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999048516A1 (en) * | 1998-03-25 | 1999-09-30 | Masterfarm, S.L. | Utilization of gelatine hydrolizats |
Also Published As
Publication number | Publication date |
---|---|
ES2104507B1 (en) | 1998-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0008059A (en) | Compositions of valdecoxib | |
BR9713400A (en) | Processes and compounds to inhibit beta-amyloid peptide release and / or its synthesis. | |
BR9714517A (en) | Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising them and processes to inhibit beta-amyloid peptide release and / or its synthesis by using such compounds | |
BG101118A (en) | Therapeutical compounds | |
HUP9901144A2 (en) | Pharmaceutical compositions containing new associations of clopidogrel and an antithrombotic agent | |
DE69920757D1 (en) | IMMUNE SUPPRESSIVE EFFECTS OF PTERIDINE DERIVATIVES | |
DE122010000050I1 (en) | SUBLINGUAL OR BUKKALES MEDICINES | |
BG106030A (en) | Pharmaceutical composition | |
PT782449E (en) | MANUFACTURING PROCESS OF HUMIDITY GRANULATION DOSAGE UNITS | |
BG103740A (en) | Phytostyrene composition for the prevention of the alzheimer's disease | |
TR200001982T2 (en) | Pharmaceutical shot-release oral dosage form. | |
NZ334124A (en) | Use of the chelating agent clioquinol, with vitamin B12 for the manufacture of a pharmaceutical composition for the treatment of alzheimer's disease | |
ATE272628T1 (en) | SUBSTITUTED GAMMA-PHENYL-DELTA-LACTONES AND ANALOGUES THEREOF, AND USES THEREOF | |
FI964332A (en) | Use of certain methanebisphosphonic acid derivatives to prevent prosthesis loosening and prosthesis migration | |
ATE218581T1 (en) | CYCLOSPORINE DERIVATIVE, PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITION | |
ATE316794T1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING LYSOSTAPHIN ALONE OR IN COMBINATION WITH AN ANTIBIOTIC FOR THE TREATMENT OF STAPHYLOCOCCAL INFECTIONS | |
BR9914631A (en) | Tolerance-inducing oral immunological composition for disease prevention and / or treatment and method for disease prevention and / or treatment | |
FR2705673B1 (en) | Compositions comprising amino acid derivatives, processes for their preparation and their uses. | |
DK1082131T3 (en) | Immunoregulator | |
BG104179A (en) | Phanquinon administration for the treatment of the alzheimer's disease | |
MX9707642A (en) | Pharmaceutical agents for the treatment of alzheimer's disease. | |
BG103512A (en) | Substituted pyramidine compounds and their application | |
DK0719276T3 (en) | Estradiol esters with strong oral action as well as pharmaceutical preparations containing them | |
ES2104507A1 (en) | Use of gelatin hydrolysate to prepare a pharmaceutical composition intended for the prevention and treatment of hip dysplasia in dogs. | |
DK0722325T3 (en) | Preparation for the treatment or prevention of herpes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EC2A | Search report published |
Date of ref document: 19971001 Kind code of ref document: A1 Effective date: 19971001 |
|
FD2A | Announcement of lapse in spain |
Effective date: 20150826 |